HOME  |  PRODUCTS  |  NEWS  |  SALES  |  SUPPORT  |  DOWNLOAD  |  CONTACT  |  CAREERS  |  BUY ONLINE NEW

Meet Allinea at IBM Deep Computing on September 22, 2010

IBM Deep Computing is dedicated to delivering a dynamic high-performance computing infrastructure that is designed for a Smarter Planet. Allinea are delighted to attend this important event.

Read more...

Allinea DDT 2.6 Released

Allinea announces the release of DDT 2.6, with support for the NVIDIA 3.0+ version of the CUDA Toolkit, support for Cray Fast Track Debugging and enhanced support for AIX. It is now even faster, ensuring Allinea DDT continues to be the easiest way to debug parallel applications.

Read more...

Allinea sign new collaboration agreement with CEA

Allinea sign a new collaboration agreement with French Atomic Energy Commission (CEA) to add MPC support to Allinea DDT.

Read more...

Allinea and IBM announce commitment to port DDT to Blue Gene

IBM introduces eServer Blue Gene for commercial distribution; Allinea to join other key ISVs with commercial product offering

Armonk, NY -- November 8, 2004 -- Today's introduction of IBM eServer Blue Gene system ushers-in a new era of high performance computing (HPC) for businesses and scientific uses. The system, unveiled today, will provide customers with the capability to advance science and business with unprecedented speed, ultrascale performance and extreme efficiency.

IBM eServer Blue Gene enables customers to obtain a peak performance of 5.7 teraflops, with a single full rack system, and is optimized for density, low power consumption, bandwidth, and scalability while consuming a fraction of power and floor space.With a footprint of less than one square meter, the system delivers more than ten times the performance of other supercomputers now on the market while occupying less floor space.

"The Blue Gene technology allows us to introduce a new class of high performance computing capability to industry-specific business challenges allowing our clients to deliver new or better optimized business functionality to their customers, said Colin Parris, vice president, eServer Product Management, IBM. "We are actively working with key industry partners to execute an optimal delivery of the blue gene capability into these key marketplaces."

IBM Blue Gene is the result of a research project chartered five years ago, requiring the effort and collaboration among IBM designers, engineers and master technologists, with more than $100 million dollars invested in research. Known originally as a research vehicle for the study of protein folding, it is now commercially available for purchase to qualified customers who have application workloads in a variety of science disciplines.

IBM, working with partners, is making Blue Gene applicable for workloads across a variety of disciplines. IBM and many national lab and university members are enabling a growing list of HPC applications and codes in areas of life sciences, financial modeling (not underway yet), hydrodynamics, quantum chemistry, molecular dynamics, astronomy and space research, and climate modeling. Other areas of interest include grid computing, business intelligence, risk and compliance, aerodynamics study and testing and manufacturing processes.

Many key software vendors such as LSTC, Platform Computing and Allinea have specified an interest in enabling their applications on Blue Gene.

Read the full IBM press release here...

More news....